43
report
Bladder Cancer - A Giving Smarter Guide
More than 500,000 people in the US suffer from bladder cancer. At the time of this report, it
was the fifth most common cancer in the US. It is also the most expensive cancer to treat and frequently reoccurs.
+ Read More
report
Alzheimer's Disease - A Giving Smarter Guide
Alzheimer’s disease is increasingly in the spotlight after a number of high-profile clinical trial
failures—an alarming trend as an estimated 5.5 million adult Americans live with this disease, which disproportionally affects the aged population.
+ Read More
report
Kidney Failure - A Giving Smarter Guide
This Giving Smarter Guide is the culmination of a year-long effort to identify strategic philanthro
pic opportunities that can move the needle on unmet needs specific to kidney failure research and treatment. Kidney failure is an irreversible diseas
+ Read More
report
Alzheimer's Disease: A Giving Smarter Guide to Accelerate Development of New Therapies
The need is staggering. Alzheimer's disease is the sixth leading cause of death in the United State
s and currently, more than 5.5 million Americans are living with this disease for which there is yet no cure yet.
+ Read More
report
Funding Scientific Research - A Giving Smarter Guide
Making an Impact. Strategic philanthropic investments in medical research require a careful conside
ration of the philanthropist’s priorities and an understanding of the current state of research to amplify the impact of their giving.
+ Read More
report
Targeting Tau — Our Hope to Solving the Dementia Crisis
In our systems-based review of the biomedical landscape supporting research of a cellular protein c
alled tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and the , At present, no disease-modifying therapies for the pure tauopathies exist. Researchers are working to develop effective therapeutic agents, which include approaches such as decreasing the amount of tau within the brain., Symptomatic Interventions
At present, no disease-modifying therapies for the pure tauopathies exist.
+ Read More
report
Misophonia - A Giving Smarter Guide
report
Nonprofits: A Growing Force in Drug Development
Shepherding a drug from discovery to the market is a complex process that involves many actors.
report
A New Imperative for Private Research Funders
COVID-related impacts on biomedical research logistics, funding, and human talent have put the enti
re biomedical research ecosystem at risk.
+ Read More
report
GBM: Giving Smarter
Glioblastoma Multiforme (GBM) is an aggressive malignant brain tumor involving glial cells of the b
rain. At the time of this report, nearly 15,000 people were diagnosed with GBM each year in the United States and Europe.
+ Read More
report
The Value of Building an Interdisciplinary Scientific Workforce — A Call to Philanthropy
The challenges that science strives to solve are increasingly complex, and making progress toward t
hem requires constant innovation and the expertise of multiple fields of study.
+ Read More
report
Supporting Wellness: Initial Findings from a Survey of Lived Experience and Research Priorities of Depression and Bipolar
In 2018, the Milken Institute Center for Strategic Philanthropy and the Depression and Bipolar Supp
ort Alliance collaborated to develop a first of its kind community survey.
+ Read More